A

Alnylam Pharmaceuticals

Develops RNAi-based therapies for genetic diseases

Quality Control Analyst 3

Regulatory & Quality (Life Sciences)Confirmed live in the last 24 hours
Full-time$88.7k - $120.1k

About the Job

Requirements

  • A B.S. in chemistry, biology, biochemistry, or a related scientific field is required.
  • Six to ten years of pharmaceutical or biotechnology industry experience in a GMP Quality Control function or equivalent relevant industry experience is required.
  • Experience in method transfer and/or analytical method implementation is required; a solid understanding of method lifecycle management and a phase-appropriate approach is desirable.
  • Demonstrated technical writing skills are required; technical writing of investigations is preferred.
  • Proficiency in data analysis and interpretation is required.
  • Problem-solving skills and experience conducting investigations and implementing corrective and preventive actions (CAPA) are required.
  • Organizational skills and the ability to manage multiple tasks simultaneously and autonomously are required.
  • Experience adhering to good manufacturing practice (GMP), good laboratory practice (GLP), and International Council for Harmonisation (ICH) guidelines is required.
  • The ability to work effectively with QC and cross-functional teams is required.

Responsibilities

  • Perform routine and non-routine analytical assays supporting raw materials, in-process samples, product release, and stability studies, following established standard operating procedures (SOPs).
  • Maintain up-to-date training records, adhere to the testing schedule, and complete assignments in a timely manner to support QC operations and project timelines and quality metrics.
  • Assist with laboratory equipment and inventory maintenance, including preparation of reagents and samples.
  • Review data in a timely manner and qualify as a data reviewer to support timely data availability.
  • Perform role-specific operational assignments, including analytical method transfer, release, stability, and in-process testing.
  • Revise and update controlled documents, including SOPs, work instructions, and test methods, to support continuous improvement and compliance with industry standards and regulatory requirements.
  • Follow internal standards, policies, and SOPs, as well as regulatory and industry standards including GMP, GLP, and ICH guidelines.
  • Identify and suggest improvements to methods and laboratory processes, particularly to improve efficiency and reliability.
  • Collaborate with QC and cross-functional teams to support quality control operations.
  • Pursue ongoing training and development in QC testing techniques, TOQ operations, and regulatory compliance.
  • May assist with technical documentation for regulatory submissions by verifying data and ensuring accuracy and regulatory compliance.
  • Participate in inspection-readiness activities and support onsite audits and inspections as needed.
  • Participate in continuous-improvement initiatives to enhance QC processes and procedures and increase laboratory efficiency and effectiveness.
  • Collaborate with CMC Development, Manufacturing, Manufacturing Technical Services, Materials Management, and Quality Assurance to align with business goals.

Desired Qualifications

  • Proficiency in LabWare LIMS, Excel, Word, and PowerPoint is preferred.

About the Company

Alnylam Pharmaceuticals

Develops RNAi-based therapies for genetic diseases

Alnylam Pharmaceuticals develops RNA interference (RNAi) therapeutics to silence disease-causing genes, aiming to treat rare genetic disorders. Its products work by using RNA molecules that block gene expression, reducing the impact of specific genetic diseases. The company differentiates itself by concentrating on RNAi-based drugs for rare diseases and by building a pipeline through large clinical programs and strategic partnerships, such as commercialization deals in the Gulf States and collaborations with investors. Revenue comes from approved drug sales, licensing agreements, strategic collaborations, and related services like genetic testing and counseling. The company’s goal is to advance and commercialize RNAi therapies to improve outcomes for patients with genetic disorders, expanding its portfolio through partnerships and investments.

Company size
1,001-5,000
Company stage
IPO
Headquarters
Cambridge, MA
Founded
2002

Recently Posted Jobs

Explore more opportunities at Alnylam Pharmaceuticals

See more jobs